NCT01433835View on ClinicalTrials.gov

Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Adult Subjects
Interventions
DRUG

MBX-400

Capsule(s) for oral administration as a single dose. Planned doses include: 35, 100, 350, 700, 1000 and 1350 mg.

OTHER

Placebo

Capsule(s) for oral administration as a single dose. Planned doses include: 35, 100, 350, 700, 1000 and 1350 mg.

Trial Locations (1)

07601

Frontage Clinical Research Center, Hackensack

Sponsors

Lead Sponsor

Microbiotix, Inc.
All Listed Sponsors
lead

Microbiotix, Inc.

INDUSTRY

NCT01433835 - Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers | Biotech Hunter | Biotech Hunter